Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
Author:
Funder
Varian Medical Systems
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference52 articles.
1. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol.,2016
2. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010;Ostrom;Neuro Oncol.,2013
3. Improved survival time trends for glioblastoma using the SEER 17 population-based registries;Koshy;J Neurooncol.,2012
4. Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis;Brown;JAMA Oncol.,2016
5. IDH1 and IDH2 mutations in gliomas;Yan;N Engl J Med.,2009
Cited by 119 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A perioperative study of Safusidenib in patients with IDH1 -mutated glioma;Future Oncology;2024-08-14
2. Lack of mismatch repair enhances resistance to methylating agents for cells deficient in oxidative demethylation;Journal of Biological Chemistry;2024-08
3. AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastoma;BMC Cancer;2024-07-24
4. Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma;Acta Neuropathologica;2024-07-16
5. Target-Driven Tissue-Agnostic Drug Approvals—A New Path of Drug Development;Cancers;2024-07-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3